Ngan J, O'Neal DN, Lee MH, Kong YW, et al. Revisiting the benefits vs risk profile of sodium-glucose co-transporter inhibitor use in type 1 diabetes. Part B: Risks of sodium-glucose co-transporter inhibitor use in type 1 diabetes and ketoacidosis risk mitigation strategies. Diabetes Res Clin Pract 2025;226:112284.
PMID: 40441606